BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 17456509)

  • 21. Serological markers of inflammatory bowel disease in children from the Western region of Saudi Arabia.
    Saadah OI; Al-Mughales JA
    Arab J Gastroenterol; 2013 Jun; 14(2):78-82. PubMed ID: 23820506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical significance of antimicrobial serologic responses within an Irish Crohn's disease population.
    O'Donnell S; O'Sullivan M; O'Morain CA; Ryan BM
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1464-9. PubMed ID: 24047859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Possible pathogenic role of vascular, immunologic and genetic factors in certain gastroenterologic disorders].
    Papp M
    Orv Hetil; 2008 Nov; 149(48):2269-76. PubMed ID: 19028649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction between seroreactivity to microbial antigens and genetics in Crohn's disease: is there a role for defensins?
    Lakatos PL; Altorjay I; Mándi Y; Lakatos L; Tumpek J; Kovacs A; Molnar T; Tulassay Z; Miheller P; Palatka K; Szamosi T; Fischer S; Papp J; ; Papp M
    Tissue Antigens; 2008 Jun; 71(6):552-9. PubMed ID: 18397186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with complicated Crohn's disease behavior.
    Rieder F; Schleder S; Wolf A; Dirmeier A; Strauch U; Obermeier F; Lopez R; Spector L; Fire E; Yarden J; Rogler G; Dotan N; Klebl F
    Inflamm Bowel Dis; 2010 Feb; 16(2):263-74. PubMed ID: 19653286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies in inflammatory bowel diseases.
    Kiliç ZM; Tunç B; Ayaz S; Filik L; Aktaş S; Parlak E; Ulker A
    Turk J Gastroenterol; 2004 Dec; 15(4):238-42. PubMed ID: 16249978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic and serological markers to identify phenotypic subgroups in a Dutch Crohn' s disease population.
    Linskens RK; Mallant-Hent RC; Murillo LS; von Blomberg BM; Alizadeh BZ; Peña AS
    Dig Liver Dis; 2004 Jan; 36(1):29-34. PubMed ID: 14971813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to Saccharomyces cerevisiae: are they useful in clinical practice?
    Candelli M; Papa A; Nista EC; Danese S; Armuzzi A; Bartolozzi F; Tondi P; Ojetti V; Gasbarrini G; Gasbarrini A
    Hepatogastroenterology; 2003; 50(51):718-20. PubMed ID: 12828069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical utility of anti-glycan antibodies in pediatric Crohn's disease in comparison with an adult cohort.
    Rieder F; Hahn P; Finsterhoelzl L; Schleder S; Wolf A; Dirmeier A; Lopez R; Shen B; Rogler G; Klebl F; Lang T
    Inflamm Bowel Dis; 2012 Jul; 18(7):1221-31. PubMed ID: 22147427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic utility of serological biomarkers in patients with Crohn's disease: A case-control study.
    Yao F; Fan Y; Lv B; Ji C; Xu L
    Medicine (Baltimore); 2018 Aug; 97(32):e11772. PubMed ID: 30095633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. pANCA and ASCA in Children with IBD-Unclassified, Crohn's Colitis, and Ulcerative Colitis-A Longitudinal Report from the IBD Porto Group of ESPGHAN.
    Birimberg-Schwartz L; Wilson DC; Kolho KL; Karolewska-Bochenek K; Afzal NA; Spray C; Romano C; Lionetti P; Hauer AC; Martinez-Vinson C; Veres G; Escher JC; Turner D;
    Inflamm Bowel Dis; 2016 Aug; 22(8):1908-14. PubMed ID: 27135480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serologic markers in inflammatory bowel disease: state of the art.
    Sandborn WJ
    Rev Gastroenterol Disord; 2004; 4(4):167-74. PubMed ID: 15580151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Assessment of antibodies anti-saccharomyces cerevisiae (ASCA) and autoantibodies in patients with inflammatory bowel disease].
    Beltrão M; Bodas A; Azevedo F; Nunes A; Santos C; Delgado L
    Acta Med Port; 2010; 23(5):829-36. PubMed ID: 21144323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.
    Gologan S; Iacob R; Preda C; Vadan R; Cotruta B; Catuneanu AM; Iacob S; Constantinescu I; Gheorghe L; Iobagiu S; Gheorghe C; Diculescu M
    J Gastrointestin Liver Dis; 2012 Mar; 21(1):39-44. PubMed ID: 22457858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Reese GE; Constantinides VA; Simillis C; Darzi AW; Orchard TR; Fazio VW; Tekkis PP
    Am J Gastroenterol; 2006 Oct; 101(10):2410-22. PubMed ID: 16952282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Initial experience with detection of Saccharomyces cerevisiae antibodies in patients with primary nonspecific inflammatory bowel disease].
    Malícková K; Janatková I; Fucíková T; Adamec S; Lukás M
    Epidemiol Mikrobiol Imunol; 2001 Aug; 50(3):131-5. PubMed ID: 11550421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroreactivity to E. coli outer membrane protein C antibodies in active inflammatory bowel disease; diagnostic value and correlation with phylogroup B2 E. coli infection.
    Petersen AM; Schou C; Mirsepasi H; Engberg J; Friis-Møller A; Nordgaard-Lassen I; Wildt S; Krogfelt KA
    Scand J Gastroenterol; 2012 Feb; 47(2):155-61. PubMed ID: 22150030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease.
    Kim BG; Kim YS; Kim JS; Jung HC; Song IS
    Dis Colon Rectum; 2002 Aug; 45(8):1062-9. PubMed ID: 12195191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Interest of serologic markers in inflammatory bowel disease. About 105 cases].
    Fekih M; Ben Hlima S; Zitouni M; Matri S; Boubaker J; Makni S; Azza F
    Tunis Med; 2007 Oct; 85(10):821-8. PubMed ID: 18236802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.